Abstract:
The invention concerns a lipid fraction (AL) derived from natural sources which can be used for in vitro and in vitro treatment of a variety of disorders. The lipid fraction contains 40-80 weight percent glycerides, 3-5 weight percent cholesterol, 10-30 weight percent lecithin (phosphatidyl choline), 5-15 weight percent phosphatidyl ethanolamine and 2-5 weight percent negatively charged phospholipids, wherein the ratio of unsaturated to saturated fatty acids is at least 1:1.